Eton Pharmaceuticals (ETON) News Today $3.58 +0.01 (+0.28%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 3:37 PM | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Indivior (INDV)July 23 at 2:53 AM | americanbankingnews.comEton Pharmaceuticals (NASDAQ:ETON) Trading Up 0.3%July 15, 2024 | globenewswire.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)July 1, 2024 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest UpdateEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 78,700 shares, an increase of 44.1% from the May 31st total of 54,600 shares. Based on an average daily trading volume, of 51,500 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.3% of the company's shares are short sold.June 13, 2024 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 35.9% in MayEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 54,600 shares, a decrease of 35.9% from the May 15th total of 85,200 shares. Based on an average daily volume of 62,700 shares, the short-interest ratio is currently 0.9 days. Approximately 0.2% of the company's stock are sold short.May 23, 2024 | msn.comHarrow (NASDAQ:HROW) Stock Surges on Successful Product LaunchMay 12, 2024 | finance.yahoo.comEton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats ExpectationsMay 10, 2024 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Posts Earnings Results, Misses Expectations By $0.01 EPSEton Pharmaceuticals (NASDAQ:ETON - Get Free Report) released its earnings results on Thursday. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). Eton Pharmaceuticals had a negative return on equity of 6.21% and a negative net margin of 2.96%. The firm had revenue of $7.97 million during the quarter, compared to analysts' expectations of $8.30 million. During the same period in the previous year, the firm posted ($0.10) earnings per share.May 10, 2024 | finance.yahoo.comQ1 2024 Eton Pharmaceuticals Inc Earnings CallMay 9, 2024 | globenewswire.comEton Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 8, 2024 | markets.businessinsider.comHere's what Wall Street expects from Eton Pharmaceuticals's earnings reportMay 7, 2024 | msn.comCraig-Hallum Initiates Coverage of Eton Pharmaceuticals (ETON) with Buy RecommendationMay 1, 2024 | globenewswire.comEton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceMay 1, 2024 | finance.yahoo.comPhenylketonuria (PKU) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor TypeApril 30, 2024 | markets.businessinsider.comEton Pharmaceuticals Announces NDA Submission For ET-400April 30, 2024 | globenewswire.comEton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)April 29, 2024 | globenewswire.comEton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024April 26, 2024 | marketbeat.comAcuitas Investments LLC Raises Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Acuitas Investments LLC boosted its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 124.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 492,054 shares of the company's stockApril 26, 2024 | msn.comPE Advent International queues up for a stake in Apollo 24/7April 2, 2024 | marketbeat.comShort Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expands By 6.9%Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 242,900 shares, a growth of 6.9% from the February 29th total of 227,200 shares. Based on an average daily trading volume, of 75,100 shares, the short-interest ratio is presently 3.2 days. Approximately 1.1% of the company's shares are sold short.March 22, 2024 | markets.businessinsider.comEton Pharma Buys U.S. Rights To PKU GOLIKE From Relief TherapeuticsMarch 22, 2024 | finance.yahoo.comRelief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKEMarch 22, 2024 | globenewswire.comEton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaMarch 17, 2024 | theguardian.com‘I don’t think I developed emotionally’: Earl Spencer on the pain of boarding-school abuseMarch 17, 2024 | investing.comEarnings call: Eton Pharmaceuticals reports robust Q4 growthMarch 16, 2024 | finance.yahoo.comETON Apr 2024 5.000 callMarch 16, 2024 | seekingalpha.comEton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | benzinga.comRecap: Eton Pharmaceuticals Q4 EarningsMarch 15, 2024 | finance.yahoo.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 Eton Pharmaceuticals Inc Earnings CallMarch 14, 2024 | finance.yahoo.comEton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...March 14, 2024 | globenewswire.comEton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 13, 2024 | benzinga.comEton Pharmaceuticals Earnings PreviewMarch 13, 2024 | msn.comEton Pharmaceuticals Q4 2023 Earnings PreviewMarch 13, 2024 | markets.businessinsider.comEton Pharmaceuticals earnings preview: what Wall Street is expectingMarch 13, 2024 | msn.comEarl Spencer’s horrific first experience of sex was all too typical for an upper-class maleMarch 12, 2024 | thetimes.co.ukCharles Spencer: ‘Boarding school killed a part of me’March 11, 2024 | washingtonpost.comPrincess Di’s brother, Charles Spencer, recounts childhood horrorsMarch 11, 2024 | msn.comCharles Spencer, Princess Diana’s brother, speaks out about ‘devastating’ abuse at British boarding schoolMarch 11, 2024 | thetimes.co.ukBoris Johnson’s secret flight to meet autocrat Maduro in VenezuelaMarch 11, 2024 | msn.comEarl Spencer reveals abuse at boarding schoolFebruary 29, 2024 | globenewswire.comEton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024February 23, 2024 | marketbeat.com256,623 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by EAM Investors LLCEAM Investors LLC acquired a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 256,623 shares of the company's stock, valued at approximately $1,0February 22, 2024 | benzinga.comEton Pharmaceuticals Stock (NASDAQ:ETON) Dividends: History, Yield and DatesFebruary 21, 2024 | globenewswire.comEton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationFebruary 6, 2024 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 2%Eton Pharmaceuticals (NASDAQ:ETON) Trading 2% HigherJanuary 23, 2024 | finance.yahoo.comEton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years agoJanuary 10, 2024 | marketbeat.comAcuitas Investments LLC Has $913,000 Stock Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Acuitas Investments LLC lessened its holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 57.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 219,000 shares of the company's stock after selling 291,0December 27, 2023 | benzinga.comEton Pharmaceuticals Stock (NASDAQ:ETON), Analyst Ratings, Price Targets, PredictionsDecember 14, 2023 | finance.yahoo.com5 Under-$15 Stocks Wall Street Analysts Recommend Buying Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.820.62▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼31▲ETON Articles Average Week Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ASMB News SLGL News GLYC News VNDA News QTTB News XERS News ACIU News KMDA News INZY News NKTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.